197 related articles for article (PubMed ID: 23945544)
1. Amelioration of ovalbumin-induced allergic airway disease following Der p 1 peptide immunotherapy is not associated with induction of IL-35.
Moldaver DM; Bharhani MS; Wattie JN; Ellis R; Neighbour H; Lloyd CM; Inman MD; Larché M
Mucosal Immunol; 2014 Mar; 7(2):379-90. PubMed ID: 23945544
[TBL] [Abstract][Full Text] [Related]
2. Subcutaneous immunotherapy with purified Der p1 and 2 suppresses type 2 immunity in a murine asthma model.
Hesse L; van Ieperen N; Habraken C; Petersen AH; Korn S; Smilda T; Goedewaagen B; Ruiters MH; van der Graaf AC; Nawijn MC
Allergy; 2018 Apr; 73(4):862-874. PubMed ID: 29318623
[TBL] [Abstract][Full Text] [Related]
3. Phenotype analyses of IL-10-producing Foxp3
Matsuda M; Morie Y; Oze H; Doi K; Tsutsumi T; Hamaguchi J; Inaba M; Nabe T
Int Immunopharmacol; 2018 Aug; 61():297-305. PubMed ID: 29909233
[TBL] [Abstract][Full Text] [Related]
4. A hypoallergenic peptide mix containing T cell epitopes of the clinically relevant house dust mite allergens.
Huang HJ; Curin M; Banerjee S; Chen KW; Garmatiuk T; Resch-Marat Y; Carvalho-Queiroz C; Blatt K; Gafvelin G; Grönlund H; Valent P; Campana R; Focke-Tejkl M; Valenta R; Vrtala S
Allergy; 2019 Dec; 74(12):2461-2478. PubMed ID: 31228873
[TBL] [Abstract][Full Text] [Related]
5. Der p 1-specific regulatory T-cell response during house dust mite allergen immunotherapy.
Boonpiyathad T; Sokolowska M; Morita H; Rückert B; Kast JI; Wawrzyniak M; Sangasapaviliya A; Pradubpongsa P; Fuengthong R; Thantiworasit P; Sirivichayakul S; Kwok WW; Ruxrungtham K; Akdis M; Akdis CA
Allergy; 2019 May; 74(5):976-985. PubMed ID: 30485456
[TBL] [Abstract][Full Text] [Related]
6. Effect of mite allergenic components on innate immune response: Synergy of protease (Group 1 & 3) and non-protease (Group 2 & 7) allergens.
Yin SC; Liao EC; Ye CX; Chang CY; Tsai JJ
Immunobiology; 2018; 223(6-7):443-448. PubMed ID: 29398016
[TBL] [Abstract][Full Text] [Related]
7. IL-33-mediated innate response and adaptive immune cells contribute to maximum responses of protease allergen-induced allergic airway inflammation.
Kamijo S; Takeda H; Tokura T; Suzuki M; Inui K; Hara M; Matsuda H; Matsuda A; Oboki K; Ohno T; Saito H; Nakae S; Sudo K; Suto H; Ichikawa S; Ogawa H; Okumura K; Takai T
J Immunol; 2013 May; 190(9):4489-99. PubMed ID: 23547117
[TBL] [Abstract][Full Text] [Related]
8. Experimental gastrointestinal allergy enhances pulmonary responses to specific and unrelated allergens.
Brandt EB; Scribner TA; Akei HS; Rothenberg ME
J Allergy Clin Immunol; 2006 Aug; 118(2):420-7. PubMed ID: 16890767
[TBL] [Abstract][Full Text] [Related]
9. Follicular helper T cells are responsible for IgE responses to Der p 1 following house dust mite sensitization in mice.
Noble A; Zhao J
Clin Exp Allergy; 2016 Aug; 46(8):1075-82. PubMed ID: 27138589
[TBL] [Abstract][Full Text] [Related]
10. Reversal of established CD4+ type 2 T helper-mediated allergic airway inflammation and eosinophilia by therapeutic treatment with DNA vaccines limits progression towards chronic inflammation and remodelling.
Jarman ER; Lamb JR
Immunology; 2004 Aug; 112(4):631-42. PubMed ID: 15270735
[TBL] [Abstract][Full Text] [Related]
11. Kinetics and mode of peptide delivery via the respiratory mucosa determine the outcome of activation versus TH2 immunity in allergic inflammation of the airways.
Hall G; Lund L; Lamb JR; Jarman ER
J Allergy Clin Immunol; 2002 Dec; 110(6):883-90. PubMed ID: 12464955
[TBL] [Abstract][Full Text] [Related]
12. Hypoallergenic Der p 1/Der p 2 combination vaccines for immunotherapy of house dust mite allergy.
Chen KW; Blatt K; Thomas WR; Swoboda I; Valent P; Valenta R; Vrtala S
J Allergy Clin Immunol; 2012 Aug; 130(2):435-43.e4. PubMed ID: 22789398
[TBL] [Abstract][Full Text] [Related]
13. IL-10 and regulatory T cells cooperate in allergen-specific immunotherapy to ameliorate allergic asthma.
Böhm L; Maxeiner J; Meyer-Martin H; Reuter S; Finotto S; Klein M; Schild H; Schmitt E; Bopp T; Taube C
J Immunol; 2015 Feb; 194(3):887-97. PubMed ID: 25527785
[TBL] [Abstract][Full Text] [Related]
14. Prevention of allergic asthma by vaccination with transgenic rice seed expressing mite allergen: induction of allergen-specific oral tolerance without bystander suppression.
Suzuki K; Kaminuma O; Yang L; Takai T; Mori A; Umezu-Goto M; Ohtomo T; Ohmachi Y; Noda Y; Hirose S; Okumura K; Ogawa H; Takada K; Hirasawa M; Hiroi T; Takaiwa F
Plant Biotechnol J; 2011 Dec; 9(9):982-90. PubMed ID: 21447056
[TBL] [Abstract][Full Text] [Related]
15. Similar immune mechanisms control experimental airway eosinophilia elicited by different allergens and treatment protocols.
Hyde EJ; Wakelin KA; Daniels NJ; Ghosh S; Ronchese F
BMC Immunol; 2019 Jun; 20(1):18. PubMed ID: 31164097
[TBL] [Abstract][Full Text] [Related]
16. Opposite effects of immunotherapy with ovalbumin and the immunodominant T-cell epitope on airway eosinophilia and hyperresponsiveness in a murine model of allergic asthma.
Janssen EM; Wauben MH; Jonker EH; Hofman G; Van Eden W; Nijkamp FP; Van Oosterhout AJ
Am J Respir Cell Mol Biol; 1999 Jul; 21(1):21-9. PubMed ID: 10385589
[TBL] [Abstract][Full Text] [Related]
17. House dust mite Dermatophagoides farinae augments proinflammatory mediator productions and accessory function of alveolar macrophages: implications for allergic sensitization and inflammation.
Chen CL; Lee CT; Liu YC; Wang JY; Lei HY; Yu CK
J Immunol; 2003 Jan; 170(1):528-36. PubMed ID: 12496440
[TBL] [Abstract][Full Text] [Related]
18. Allergen-specific production of interferon-gamma by peripheral blood mononuclear cells and CD8 T cells in allergic disease and following immunotherapy.
O'Brien RM; Xu H; Rolland JM; Byron KA; Thomas WR
Clin Exp Allergy; 2000 Mar; 30(3):333-40. PubMed ID: 10691890
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the Allergenic Potency of House Dust Extract and House Dust Mite Allergen Extract for Subcutaneous Allergen Immunotherapy.
Du W; Fukano C; Yonemoto M; Matsuoka T; Masuyama K; Ohashi-Doi K
Biol Pharm Bull; 2019; 42(4):601-606. PubMed ID: 30930419
[TBL] [Abstract][Full Text] [Related]
20. Synthesized OVA323-339MAP octamers mitigate OVA-induced airway inflammation by regulating Foxp3 T regulatory cells.
Su W; Zhong W; Zhang Y; Xia Z
BMC Immunol; 2012 Jul; 13():34. PubMed ID: 22769043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
